Clayton Medical Research Foundation Inc is located in Carson City, NV. The organization was established in 1988. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clayton Medical Research Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Clayton Medical Research Foundation Inc generated $3.3m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (2.9%) each year. All expenses for the organization totaled $3.4m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
CLAYTON MEDICAL RESEARCH FOUNDATION, INC. WAS ESTABLISHED AS A CHARITABLE NON-PROFIT CORPORATION TO SUPPORT MEDICAL AND SCIENTIFIC RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE TUMOR TARGETING TOXINS GRANT TO THE UNIVERSITY OF CALIFORNIA, SAN DIEGO, FUNDS RESEARCH DIRECTED TO THE DISCOVERY AND DEVELOPMENT OF COMPOUNDS FOR CANCER THERAPY, COMPOUNDS SYNTHESIZED WITH PROTEINS JOINED BY A SORTASE REACTION, AND COMPOUNDS WITH A VARIETY OF TARGETING LIGANDS COUPLED WITH TOXINS FOR DELIVERY TO MULTIPLE TUMOR TYPES. PATENT APPLICATIONS HAVE BEEN FILED FOR THESE TECHNOLOGIES BY RESEARCH DEVLOPMENT FOUNDATION ("RDF"), A TAX-EXEMPT SUPPORTING ORGANIZATION OF THE FOUNDATION (SEE SCHEDULE R, PART III), AND COLLABORATIONS HAVE BEEN AND ARE BEING ESTABLISHED WITH OTHER SCIENTISTS AND WITH COMMERCIAL ENTITIES AND CONSULTANTS FOR DEVELOPMENT OF DRUGS FOR HUMAN CANCER INDICATIONS.
A MEDICAL RESEARCH GRANT TO THE UNIVERSITY OF CALIFORNIA, IRVINE FOR RESEARCH COLLABORATION WITH THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER SAN ANTONIO INVOLVING THE DESIGN AND DEVELOPMENT OF NEW TECHNOLOGY AND DEVICES BASED ON THE USE OF LIGHT FOR DIAGNOSIS, GUIDANCE AND SURGERY IN CARDIOLOGICAL AND OTHER MEDICAL APPLICATIONS, INCLUDING POSSIBLE USE IN TREATMENT OF CORONARY TOTAL OCCLUSION AND CORONARY ARTERY DISEASES AND REMOVAL OF TUMORS. RESEARCH TO DATE ON THIS PROJECT HAS RESULTED IN SEVERAL ISSUED PATENTS AND A NUMBER OF PENDING PATENT APPLICATIONS FILED.
STF-1 AND GLUCOSE CONTROL GRANT TO THE SALK INSTITUTE FOR BIOLOGICAL STUDIES FOCUSES ON CHACTERIZATION OF CELLULAR PROTEINS THAT MODULATE FATTY ACID METABOLISM IN MUSCLE AND FAT; CHARACTERIZATION OF A SIGNALING MODULE THAT PROMOTES BETA CELL SURVIVAL; AND THE ROLE OF PDX (ORIGINALLY STF1) IN PROMOTING ISLET CELL PROLIFERATION.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Robert M Wallace Trustee, President | OfficerTrustee | 8 | $12,121 |
Thomas J Brorby Trustee, Chairman | OfficerTrustee | 2 | $12,121 |
Jarred W Sloan Trustee, Vice President, Treasurer | OfficerTrustee | 6 | $12,121 |
Brian W Crozier Trustee | Trustee | 2 | $12,121 |
Lynn P Carter Trustee | Trustee | 4 | $12,121 |
Joan S Dunlap Vice President, Assistant Secretary | Officer | 4 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $0 |
Investment income | $1,690,264 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $1,611,338 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,301,602 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $2,904,063 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $60,605 |
Compensation of current officers, directors, key employees. | $9,091 |
Compensation to disqualified persons | $145,919 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $3,112 |
Fees for services: Accounting | $15,366 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $167,672 |
Fees for services: Other | $18,900 |
Advertising and promotion | $0 |
Office expenses | $3,776 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $21,000 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $70,936 |
All other expenses | $0 |
Total functional expenses | $3,411,349 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $33,137 |
Savings and temporary cash investments | $3,340 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $361,056 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $50,450 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $95,111,477 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $95,559,460 |
Accounts payable and accrued expenses | $38,573 |
Grants payable | $2,674,478 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $2,713,051 |
Net assets without donor restrictions | $79,641,794 |
Net assets with donor restrictions | $13,204,615 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $95,559,460 |
Over the last fiscal year, Clayton Medical Research Foundation Inc has awarded $2,904,063 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
La Jolla, CA PURPOSE: Medical research | $1,686,000 |
La Jolla, CA PURPOSE: Medical research | $710,000 |
Irvine, CA PURPOSE: Medical research | $508,063 |
Beg. Balance | $13,204,615 |
Ending Balance | $13,204,615 |
Organization Name | Assets | Revenue |
---|---|---|
The Young Living Foundation Lehi, UT | $9,856,727 | $9,672,215 |
Sanford Consortium For Regenerative Medicine La Jolla, CA | $91,137,571 | $8,267,717 |
Sansum Diabetes Research Institute Santa Barbara, CA | $20,925,060 | $11,475,472 |
Loma Linda Veterans Association For Research And Education San Bernardino, CA | $6,134,235 | $4,191,215 |
Clayton Medical Research Foundation Inc Carson City, NV | $95,559,460 | $3,301,602 |
Bateman Horne Center Of Excellence Inc Salt Lake City, UT | $646,829 | $2,098,445 |
Turning Green Sausalito, CA | $463,819 | $790,449 |
W Edwards Deming Institute Ketchum, ID | $1,398,991 | $458,197 |
Erik & Ese Banck Clinical Research Center Inc San Diego, CA | $9,945,646 | $626,776 |
The Andrew Levitt Center For Social Emergency Medicine Berkeley, CA | $873,495 | $743,471 |
Tw Mcmath Deondue Tr Las Vegas, NV | $7,242,100 | $1,219,873 |
Alvarado Knee Research Institute Inc San Diego, CA | $389,758 | $363,141 |